Abstract
Adipose tissue plays a vital role in the development of obesity and related disorders. Our previous study showed that A20, an ubiquitin-editing enzyme with anti-inflammation function, attenuated free fatty acids (FFAs)-induced lipid accumulation in nonalcoholic steatohepatitis. Here, we investigated A20 expression in adipose tissue of obese individuals and its effects on 3T3-L1 lipogenesis as well as the likely mechanisms underlying this process. By re-annotation of raw microarray data downloaded from Gene Expression Omnibus, we found that obese individuals showed significantly higher A20 mRNA levels in adipocytes. In vitro, A20 inhibited MCP-1 and IL-6 secretion in adipocytes. Forced expression of A20 resulted in decreased expression of key markers of lipogenesis and adipogenesis, such as sterol regulatory element binding protein 1c (SREBP-1c) and adipogenesis (aP2), leading to less lipids accumulation in differentiated 3T3-L1 cells. This process was concomitant with attenuated activation of p38 and Akt signaling. Our results suggest that A20 may have therapeutic potential for obesity and related diseases. The mechanisms involved the suppression of lipid storage and inflammation in adipocytes.
Similar content being viewed by others
Abbreviations
- MCD:
-
Methionine choline-deficient
- NAFLD:
-
Nonalcoholic fatty liver disease
- NASH:
-
Nonalcoholic steatohepatitis
- FFAs:
-
Free fatty acids
- TNFAIP3:
-
TNF-α-induced protein 3
- SREBP-1c:
-
Sterol regulatory element binding protein1c
- ACC1:
-
Acetyl-CoA carboxylase 1
- FAS:
-
Fatty acid synthase
- OA:
-
Oleic acid
- PA:
-
Palmitic acid
- IL-6:
-
Interleukin-6
- Dgat2:
-
Diacylglycerol O-acyltransferase-2
- Scd-1:
-
Stearoyl-CoA desaturase
References
Guilherme A, Virbasius JV, Puri V, Czech MP (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9:367–377. doi:10.1038/nrm2391
Abenavoli L, DIR L, Guzzi PH, Pellicano R, Milic N, DEL A (2015) Non-alcoholic fatty liver disease severity, central fat mass and adinopectin: a close relationship. Clujul Med 88:489–493. doi:10.15386/cjmed-595
Jung UJ, Choi MS (2014) Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci 15:6184–6223. doi:10.3390/ijms15046184
Ajuwon KM, Spurlock ME (2005) Palmitate activates the NF-kappaB transcription factor and induces IL-6 and TNFalpha expression in 3T3-L1 adipocytes. J Nutr 135:1841–1846
Boren J, Taskinen MR, Olofsson SO, Levin M (2013) Ectopic lipid storage and insulin resistance: a harmful relationship. J Intern Med 274:25–40. doi:10.1111/joim.12071
Ai L, Xu Q, Wu C, Wang X, Chen Z, Su D, Jiang X, Xu A, Lin Q, Fan Z (2015) A20 Attenuates FFAs-induced lipid accumulation in nonalcoholic steatohepatitis. Int J Biol Sci 11:1436–1446. doi:10.7150/ijbs.13371
Verstrepen L, Verhelst K, van Loo G, Carpentier I, Ley SC, Beyaert R (2010) Expression, biological activities and mechanisms of action of A20 (TNFAIP3). Biochem Pharmacol 80:2009–2020. doi:10.1016/j.bcp.2010.06.044
Stewart TP, Kim HY, Saxton AM, Kim JH (2010) Genetic and genomic analysis of hyperlipidemia, obesity and diabetes using (C57BL/6 J x TALLYHO/JngJ) F2 mice. BMC Genom 11:713. doi:10.1186/1471-2164-11-713
Lee YH, Nair S, Rousseau E, Allison DB, Page GP, Tataranni PA, Bogardus C, Permana PA (2005) Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes. Diabetologia 48:1776–1783. doi:10.1007/s00125-005-1867-3
Onate B, Vilahur G, Camino-Lopez S, Diez-Caballero A, Ballesta-Lopez C, Ybarra J, Moscatiello F, Herrero J, Badimon L (2013) Stem cells isolated from adipose tissue of obese patients show changes in their transcriptomic profile that indicate loss in stem cellness and increased commitment to an adipocyte-like phenotype. BMC Genom 14:625. doi:10.1186/1471-2164-14-625
Gesta S, Bluher M, Yamamoto Y, Norris AW, Berndt J, Kralisch S, Boucher J, Lewis C, Kahn CR (2006) Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc Natl Acad Sci USA 103:6676–6681. doi:10.1073/pnas.0601752103
Xu AT, Li Y, Zhao D, Shen J, Xu XT, Qiao YQ, Zhu MM, Wang TR, Cui Y, Ai LY, Ran ZH (2015) High suppressor of cytokine signaling-3 expression impairs stat3-dependent protective effects of interleukin-22 in ulcerative colitis in remission. Inflamm Bowel Dis 21:241–250. doi:10.1097/MIB.0000000000000267
Chen ZF, Ai LY, Wang JL, Ren LL, Yu YN, Xu J, Chen HY, Yu J, Li M, Qin WX, Ma X, Shen N, Chen YX, Hong J, Fang JY (2015) Probiotics Clostridium butyricum and Bacillus subtilis ameliorate intestinal tumorigenesis. Future Microbiol 10:1433–1445. doi:10.2217/fmb.15.66
Chawla A, Nguyen KD, Goh YP (2011) Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol 11:738–749. doi:10.1038/nri3071
Lumeng CN, Saltiel AR (2011) Inflammatory links between obesity and metabolic disease. J Clin Invest 121:2111–2117. doi:10.1172/jci57132
He Z, Li M, Zheng D, Chen Q, Liu W, Feng L (2015) Adipose tissue hypoxia and low-grade inflammation: a possible mechanism for ethanol-related glucose intolerance? Br J Nutr 113:1355–1364. doi:10.1017/S000711451500077X
Priceman SJ, Kujawski M, Shen S, Cherryholmes GA, Lee H, Zhang C, Kruper L, Mortimer J, Jove R, Riggs AD, Yu H (2013) Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance. Proc Natl Acad Sci USA 110:13079–13084. doi:10.1073/pnas.1311557110
Wertz IE, Newton K, Seshasayee D, Kusam S, Lam C, Zhang J, Popovych N, Helgason E, Schoeffler A, Jeet S, Ramamoorthi N, Kategaya L, Newman RJ, Horikawa K, Dugger D, Sandoval W, Mukund S, Zindal A, Martin F, Quan C, Tom J, Fairbrother WJ, Townsend M, Warming S, DeVoss J, Liu J, Dueber E, Caplazi P, Lee WP, Goodnow CC, Balazs M, Yu K, Kolumam G, Dixit VM (2015) Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation. Nature 528:370–375. doi:10.1038/nature16165
Arvelo MB, Cooper JT, Longo C, Daniel S, Grey ST, Mahiou J, Czismadia E, Abu-Jawdeh G, Ferran C (2002) A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis. Hepatology 35:535–543. doi:10.1053/jhep.2002.31309
Hymowitz SG, Wertz IE (2010) A20: from ubiquitin editing to tumour suppression. Nat Rev Cancer 10:332–341. doi:10.1038/nrc2775
Duong BH, Onizawa M, Oses-Prieto JA, Advincula R, Burlingame A, Malynn BA, Ma A (2015) A20 restricts ubiquitination of pro-interleukin-1beta protein complexes and suppresses NLRP3 inflammasome activity. Immunity 42:55–67. doi:10.1016/j.immuni.2014.12.031
Cooper JT, Stroka DM, Brostjan C, Palmetshofer A, Bach FH, Ferran C (1996) A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism. J Biol Chem 271:18068–18073
Engelman JA, Lisanti MP, Scherer PE (1998) Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. J Biol Chem 273:32111–32120
Farmer SR (2006) Transcriptional control of adipocyte formation. Cell Metab 4:263–273. doi:10.1016/j.cmet.2006.07.001
Bohgaki M, Tsukiyama T, Nakajima A, Maruyama S, Watanabe M, Koike T, Hatakeyama S (2008) Involvement of Ymer in suppression of NF-kappaB activation by regulated interaction with lysine-63-linked polyubiquitin chain. Biochim Biophys Acta 1783:826–837. doi:10.1016/j.bbamcr.2007.09.006
Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP, Ma A (2000) Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289:2350–2354
Chen NK, Chong TW, Loh HL, Lim KH, Gan VH, Wang M, Kon OL (2013) Negative regulatory responses to metabolically triggered inflammation impair renal epithelial immunity in diabetes mellitus. J Mol Med (Berl) 91:587–598. doi:10.1007/s00109-012-0969-x
Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, Burgart LJ, Gores GJ (2004) Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 40:185–194. doi:10.1002/hep.20283
Opipari AW Jr, Boguski MS, Dixit VM (1990) The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J Biol Chem 265:14705–14708
Sarma V, Lin Z, Clark L, Rust BM, Tewari M, Noelle RJ, Dixit VM (1995) Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J Biol Chem 270:12343–12346
Grey ST, Arvelo MB, Hasenkamp W, Bach FH, Ferran C (1999) A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets. J Exp Med 190:1135–1146
Dorronsoro A, Lang V, Jakobsson E, Ferrin I, Salcedo JM, Fernandez-Rueda J, Fechter K, Rodriguez MS, Trigueros C (2013) Identification of the NF-kappaB inhibitor A20 as a key regulator for human adipogenesis. Cell Death Dis 4:e972. doi:10.1038/cddis.2013.494
Coornaert B, Baens M, Heyninck K, Bekaert T, Haegman M, Staal J, Sun L, Chen ZJ, Marynen P, Beyaert R (2008) T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20. Nat Immunol 9:263–271. doi:10.1038/ni1561
Duwel M, Welteke V, Oeckinghaus A, Baens M, Kloo B, Ferch U, Darnay BG, Ruland J, Marynen P, Krappmann D (2009) A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains. J Immunol 182:7718–7728. doi:10.4049/jimmunol.0803313
Longo CR, Patel VI, Shrikhande GV, Scali ST, Csizmadia E, Daniel S, Sun DW, Grey ST, Arvelo MB, Ferran C (2005) A20 protects mice from lethal radical hepatectomy by promoting hepatocyte proliferation via a p21waf1-dependent mechanism. Hepatology 42:156–164. doi:10.1002/hep.20741
Berndt J, Kovacs P, Ruschke K, Kloting N, Fasshauer M, Schon MR, Korner A, Stumvoll M, Bluher M (2007) Fatty acid synthase gene expression in human adipose tissue: association with obesity and type 2 diabetes. Diabetologia 50:1472–1480. doi:10.1007/s00125-007-0689-x
Loftus TM, Jaworsky DE, Frehywot GL, Townsend CA, Ronnett GV, Lane MD, Kuhajda FP (2000) Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288:2379–2381
Wu M, Singh SB, Wang J, Chung CC, Salituro G, Karanam BV, Lee SH, Powles M, Ellsworth KP, Lassman ME, Miller C, Myers RW, Tota MR, Zhang BB, Li C (2011) Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes. Proc Natl Acad Sci USA 108:5378–5383. doi:10.1073/pnas.1002588108
Smith SJ, Cases S, Jensen DR, Chen HC, Sande E, Tow B, Sanan DA, Raber J, Eckel RH, Farese RV Jr (2000) Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat Genet 25:87–90. doi:10.1038/75651
Zhang Z, Shu G, Zhu X, Guo J, Cai H, Wang S, Wang L, Gao P, Xi Q, Zhang Y, Yuan L, Jiang Q (2014) Effect of diacylglycerol acyltransferase 2 overexpression in 3T3-L1 is associated to an increase in mono-unsaturated fatty acid accumulation. J Anim Sci Biotechnol 5:29. doi:10.1186/2049-1891-5-29
Makowski L, Hotamisligil GS (2004) Fatty acid binding proteins—the evolutionary crossroads of inflammatory and metabolic responses. J Nutr 134:2464S–2468S
Xu A, Wang Y, Xu JY, Stejskal D, Tam S, Zhang J, Wat NM, Wong WK, Lam KS (2006) Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 52:405–413. doi:10.1373/clinchem.2005.062463
Maeda K (2007) Role of adiponectin and adipocyte fatty acid binding protein in the metabolic syndrome. Diabetes Res Clin Pract 77(Suppl 1):S17–S22. doi:10.1016/j.diabres.2007.01.028
Kilroy G, Carter LE, Newman S, Burk DH, Manuel J, Moller A, Bowtell DD, Mynatt RL, Ghosh S, Floyd ZE (2015) The ubiquitin ligase Siah2 regulates obesity-induced adipose tissue inflammation. Obesity (Silver Spring) 23:2223–2232. doi:10.1002/oby.21220
Aouadi M, Jager J, Laurent K, Gonzalez T, Cormont M, Binetruy B, Le Marchand-Brustel Y, Tanti JF, Bost F (2007) p38MAP Kinase activity is required for human primary adipocyte differentiation. FEBS Lett 581:5591–5596. doi:10.1016/j.febslet.2007.10.064
Ji J, Zhu J, Hu X, Wang T, Zhang X, Hou AJ, Wang H (2015) (2S)-7,4′-dihydroxy-8-prenylflavan stimulates adipogenesis and glucose uptake through p38MAPK pathway in 3T3-L1 cells. Biochem Biophys Res Commun 460:578–582. doi:10.1016/j.bbrc.2015.03.072
Wang S, Xu Q, Shu G, Wang L, Gao P, Xi Q, Zhang Y, Jiang Q, Zhu X (2015) N-oleoyl glycine, a lipoamino acid, stimulates adipogenesis associated with activation of CB1 receptor and Akt signaling pathway in 3T3-L1 adipocyte. Biochem Biophys Res Commun 466:438–443. doi:10.1016/j.bbrc.2015.09.046
Acknowledgments
This work was supported by grants from the Baoen Wang liver fibrosis research fund, hepatitis prevention and treatment foundation of China (No.20110002), and Key discipline construction plan of Shanghai Public Health projects (No.12GWZX0903).
Authors contribution
Luoyan Ai and Xiaohan Wang conducted the experiments. Zhiwei Chen and Antao Xu analyzed data or performed statistical analysis. Qingqing Xu, Xiaoke Jiang, Dazhi Su, and Changwei Wu collected data and provided essential reagents. Qing Lin and Zhuping Fan designed the research. Luoyan Ai wrote the paper. Zhuping Fan had primary responsibility for final content. All authors have read and approved the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interests.
Additional information
Luoyan Ai, Xiaohan Wang, and Zhiwei Chen contributed equally to this work.
Rights and permissions
About this article
Cite this article
Ai, L., Wang, X., Chen, Z. et al. A20 reduces lipid storage and inflammation in hypertrophic adipocytes via p38 and Akt signaling. Mol Cell Biochem 420, 73–83 (2016). https://doi.org/10.1007/s11010-016-2768-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-016-2768-0